SHANGHAI SERUM BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 688163 for the last quarter is 25.98 M CNY, and it's 9.65% higher compared to the previous quarter. The net income of Q1 24 is 1.47 M CNY.